| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 7.329 | 3.121 | 0 | - | 0 | 0 | 21.863 | 23.382 | 22.643 |
| Total Income - EUR | 0 | 7.329 | 3.121 | 0 | - | 0 | 0 | 21.863 | 23.384 | 23.618 |
| Total Expenses - EUR | 4 | 8.215 | 3.614 | 0 | - | 0 | 0 | 37.566 | 24.340 | 14.362 |
| Gross Profit/Loss - EUR | -4 | -886 | -493 | 0 | - | 0 | 0 | -15.704 | -956 | 9.256 |
| Net Profit/Loss - EUR | -4 | -1.106 | -587 | 0 | - | 0 | 0 | -15.922 | -1.538 | 7.775 |
| Employees | 0 | 1 | 0 | 0 | - | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Biotika Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | - | 0 | 0 | 2.520 | 1.599 | 681 |
| Current Assets | 41.924 | 38.642 | 35.442 | 34.791 | - | 33.369 | 32.629 | 521 | 13.933 | 25.871 |
| Inventories | 41.676 | 38.068 | 35.123 | 34.479 | - | 33.170 | 32.434 | 224 | 3.901 | 25.318 |
| Receivables | 216 | 214 | 210 | 207 | - | 199 | 194 | 0 | 9.217 | -281 |
| Cash | 31 | 360 | 108 | 106 | - | 0 | 0 | 296 | 815 | 835 |
| Shareholders Funds | 301 | -809 | -1.382 | -1.356 | - | -1.305 | -1.276 | -17.202 | -18.688 | -10.809 |
| Social Capital | 45 | 45 | 44 | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 41.623 | 39.450 | 36.824 | 36.148 | - | 34.673 | 33.905 | 20.410 | 34.425 | 37.361 |
| Income in Advance | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4727 - 4727" | |||||||||
| CAEN Financial Year |
4776
|
|||||||||
Comments - Biotika Med S.r.l.